The National Association of County and City Health Officials (NACCHO), in partnership with the University of Washington (UW), is recruiting syringe services programs (SSPs), local health departments (LHDs), and other harm reduction stakeholders to participate in the SSP Monitoring & Evaluation Advisory Group (SSPAG). The SSPAG will work with NACCHO, UW, and partners to increase the capacity of LHDs to establish and work with SSPs, promote monitoring and evaluation (M&E) of SSPs and the use of data for SSP program improvement, and assess trends in SSP operations and injection drug use. The SSPAG is also designed to facilitate information exchange and collaboration among LHDs, SSPs, and other federal, national, state, and local partners.
Member Eligibility and Responsibilities
The SSPAG is open to LHD-operated and community-based SSPs and other stakeholders that work with SSPs. SSPAG members should have experience in SSP M&E including the collection, reporting, analysis, and evaluation of SSP data; the use of SSP data to support program improvement; or the design or implementation of systems to support this work. Participants will provide input and guidance to NACCHO and/or UW through group or individual calls and email-based requests for information. The time commitment is anticipated to be approximately 1-2 hours per month between January and December 2021.
How the SSP Advisory Group Differs from NACCHO’s Harm Reduction Community of Practice
NACCHO also operates a Harm Reduction Community of Practice (CoP) that seeks to increase the capacity of LHDs to implement or scale up SSPs and other harm reduction strategies. The SSPAG and CoP differ in several key ways. The SSPAG is open to all SSPs and other harm reduction stakeholders while the CoP is open to LHDs that implement any harm reduction strategies; the SSPAG is focused primarily on SSP M&E and the use of data to strengthen harm reduction efforts while the CoP is focused more broadly on harm reduction best practices; and the SSPAG will meet on an ad-hoc basis and will often provide feedback via email, whereas the CoP primarily operates through bi-monthly calls. LHDs can participate in both groups and may designate the same or different staff as the main points of contact. To learn more about the CoP, visit here. Contact Kat Kelley, Senior Program Analyst, HIV, STI, & Viral Hepatitis (email@example.com) with questions, to join the CoP, or to discuss which group(s) your organization should participate in or which staff should participate.